FIRST WAVE BIOPHARMA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.74 USD | +0.37% |
|
+5.38% | -34.76% |
| 03-29 | First Wave BioPharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 03-14 | Sector Update: Health Care Stocks Retreating Late Afternoon | MT |
Chart calendar First Wave BioPharma, Inc.
c722133dd83437c162e3c05.Ni5NZlq_05QthI1jBhp0TERUlcPHyDBYw-XValur9Dk.G0kaEhOIi9t-3Lglc2MgfhRg1LKqvQc5tIulOzTxrXNOGSYVBYy13xvi-g~5c252d85613e548ae58ca5b8faed3425
Upcoming events on First Wave BioPharma, Inc.
Past events on First Wave BioPharma, Inc.
| 18/03/2024 17:30 | ROTH Conference |
| 14/03/2024 12:30 | Business Update Call |
| 27/02/2024 18:15 | BIO CEO & Investor Conference |
| 01/02/2024 21:00 | Dealflow Microcap Conference |
| 31/01/2024 15:50 | Dealflow Microcap Conference |
| 29/01/2024 | Dealflow Microcap Conference |
| 24/01/2024 14:30 | Sequire Investor Summit |
| 07/01/2024 | BIO Partnering JPM Week |
| 06/01/2024 16:30 | Longwood Healthcare Leaders CEO Conference |
| 12/12/2023 14:00 | Extraordinary Shareholders Meeting |
| 01/11/2023 | North American Cystic Fibrosis Conference |
| 17/10/2023 19:15 | BIO Investor Forum |
| 12/10/2023 13:15 | Roth Healtcare Opportunities Conference |
| 11/09/2023 12:00 | H.C. Wainwright Global Investment Conference |
| 27/07/2023 | National Cystic Fibrosis Education Conference |
| 22/06/2023 14:00 | Annual General Meeting |
| 06/06/2023 16:45 | BIO International Conference |
| 22/05/2023 | World Orphan Drug Congress |
| 09/05/2023 | EF Hutton Global Conference |
| 07/05/2023 16:45 | Digestive Disease Week |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -14,7 -18,0 18.18% | -26,4 -13,3 -98.2% | -59,1 -58,2 -1.43% | -12,7 -13,1 2.96% | -15,8 -15,2 -4.02% | -21,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -15,2 -18,4 17.63% | -32,7 -21,0 -55.53% | -58,5 -60,2 2.77% | -14,6 -13,9 -5.09% | -15,8 -15,3 -3.28% | -21,3 |
|
Net income Million USD | Released Forecast Spread | -15,2 -18,4 17.32% | -41,7 -23,3 -79.14% | -84,5 -60,1 -40.54% | -14,6 -14,3 -2.31% | -16,1 -15,4 -4.5% | -21,3 |
|
EPS USD | Released Forecast Spread | -28 560 -34 020 16.05% | -48 300 -34 335 -40.67% | -39 774 -29 379 -35.38% | -420 -124 -237.62% | -47,9 -41,5 -15.48% | -1,80 |
| Announcement Date | 30/03/20 | 31/03/21 | 31/03/22 | 20/03/23 | 29/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -11,2 -10,3 -8.05% | -9,38 -8,84 -6.18% | -5,41 -8,69 37.81% | 4,39 -3,58 222.61% | -2,28 -2,67 14.51% | -4,06 -2,92 -39.2% | -4,18 -3,40 -22.88% | -3,43 -4,22 18.7% | -4,09 -3,48 -17.51% | -4,14 | -4,76 | -5,63 | -6,74 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -11,2 -10,3 -8.23% | -9,63 -8,84 -8.95% | -5,41 -8,69 37.79% | 4,39 -3,58 222.66% | -3,99 -2,67 -49.48% | -4,07 -2,92 -39.48% | -4,19 -3,40 -23.1% | -3,43 -4,22 18.68% | -4,10 -3,48 -17.72% | -4,14 | -4,76 | -5,63 | -6,74 |
|
Net income Million USD | Released Forecast Spread | -11,3 -10,3 -9.22% | -10,3 -8,84 -16.71% | -5,55 -8,69 36.13% | 4,23 -3,58 218.26% | -3,99 -2,67 -49.48% | -4,16 -2,92 -42.47% | -4,28 -3,40 -25.88% | -3,48 -4,22 17.51% | -4,18 -3,48 -19.94% | -4,14 | -4,76 | -5,63 | -6,74 |
|
EPS USD | Released Forecast Spread | 714 -3 738 119.1% | -2 772 -2 226 -24.53% | -1 050 -1 680 37.5% | 364 -421 186.38% | -189 -8,30 -2181.93% | -36,4 -42,6 14.55% | -37,8 -20,8 -81.73% | -9,20 -11,2 17.86% | -44,7 -4,04 -1008.05% | -2,43 | -0,32 | -0,37 | -0,43 |
| Announcement Date | 31/03/22 | 23/05/22 | 15/08/22 | 14/11/22 | 20/03/23 | 12/05/23 | 14/08/23 | 13/11/23 | 29/03/24 | - | - | - | - |
More events
Past sector events for First Wave BioPharma, Inc.
| 26/04/2024 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 06:00 | BB BIOTECH AG: Q1 2024 Earnings Release |
| 25/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 25/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 25/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 12:00 | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 25/04/2024 07:00 | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- FWBI Stock
- Calendar First Wave BioPharma, Inc.
